Rationale: Non-Hodgkin lymphoma remains an unpredictable condition in pediatric patients.
Introduction
Lymphoma is a malignant condition of the blood with an annual incidence of 15 cases per 1 million children in the USA, representing the 3rd most common cancers in pediatric age. [1] Lymphomas are divided in 2 main categories: Hodgkin (HL) and non-Hodgkin lymphomas (NHL), with specific clinical manifestations and treatment. In children, NHL comprises 4 wide categories: lymphoblastic lymphoma, Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), and anaplastic large cell lymphoma. Even though most of the children present with the novo NHL, some of these cases may be secondary to other etiologies, such as: inherited or acquired immune deficiencies, viruses, or are included in the spectrum of genetic syndromes. and central nervous system were the most common types of malignancies. [2] For example, in Africa, the incidence of BL is approximately 50-fold higher than that encountered in the USA, [3] therefore being named endemic BL. Besides, endemic BL, there are also defined another 2 types of BL, sporadic and immunodeficient.
The clinical appearance of HHL in children depends in all cases on sites of involvement and the pathologic subtype. Therefore, lymphoblastic lymphoma presents most commonly as an intrathoracic or mediastinal mass and own a predilection for metastasizing in the bone marrow or central nervous system. Like-wise BL can also spread to those 2 sites, but it usually manifests and an abdominal mass in case of sporadic type, or head and neck in case of endemic type. On the other hand, DLBCL rarely metastasizes to the bone marrow or central nervous system, but it can manifest as both abdominal or mediastinal mass. Last, but not least, anaplastic large cell lymphoma is a particular type, which can present as a primary cutaneous tumor or a systemic disease, and is usually spreads to liver, lungs, spleen, and mediastinum, rarely in bone marrow or central nervous system. [1] Most common manifestations related to the tumor site are: fast lymph node enlargement without associated pain, cough, or dyspnea in case of intrathoracic masses, even superior mediastinal syndrome; ascites and increase of the abdominal perimetrium or bowel obstruction in case of abdominal masses; while in case of Waldeyer ring involvement, nasal congestion, earache, hearing loss, or tonsils enlargement are the most frequent symptoms; and bone pain in case of bone metastases. [1] In particular cases, NHL can also manifest as a lifethreatening oncologic condition requiring intensive supportive care, like: superior mediastinal syndrome, acute paraplegias (spinal cord tumors), renal failure, or cardiac impairment due to tumor lysis syndrome, especially in BL, which can lead to hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia. [1] The treatment for children diagnosed with NHL includes multiagent systemic chemotherapy with intrathecal administration, surgical intervention is used mainly for diagnosing the tumors, while radiation therapy is only for central nervous system involvement, superior mediastinal syndrome, or paraplegias. [1] We present this case series of abdominal lymphomas with the aim of underlining the variability of diagnostic and prognostic particularities encountered in children diagnosed with NHL.
The informed consent was obtained from the patients' mothers (legal guardians) for the publication of these cases.
Case series
2.1. Case 1 2.1.1. Presenting concerns. We present the case of an 8-yearold boy, admitted in our clinic with a history of recurrent abdominal pain for approximately 3 months for which he received antiparasytic drugs, weight loss (approximately 3 kg within the last month), loss of appetite, and diarrheic stools for 2 days associated with fever. His personal history revealed the fact that he was diagnosed with iron (Ir) deficiency anemia 3 months before the admission for which he received Ir supplements, but without any improvements. 65 mm/h, a low level of Ir (Ir 2.76 mmol/L), and hypoproteinemia (total proteins 5.97 g/dL). The tests for viral hepatis, toxoplasmosis, rubella, cytomegalovirus, herpes virus, and Epstein Barr virus were within normal ranges. The medullar biopsy was negative. The abdominal ultrasound showed a retroperitoneal mass of approximately 134/61.4 mm that crossed the median line, a hypoechoic mass in the liver, hepatomegaly, splenomegaly, and extrinsic compression of the urinary bladder. We performed an abdominal CT scan which suggested that the aspect of the abdominal mass could plead for an intestinal lymphoma with spleen and renal secondary determinations. Therefore, the patient underwent a surgical intervention consisting in a segmental colectomy and subsequent colostomy in order to establish the diagnosis. The histopathological exam confirmed the diagnosis of DLBCL of the bowel.
Therapeutic focus and assessment.
The patient underwent the B-NHL BFM 04 cytostatic protocol without any incidents during the treatment. We also administered supportive treatment.
2.1.5. Follow-up and outcome. Unfortunately, the patient was admitted at approximately 1 month after the completion of chemotherapy with an early recurrence presenting peritoneal carcinomatosis and multiple hepatic and renal secondary determinations. We initiated the B-NHL BFM 04 protocol, but the parents requested the cessation of the treatment and the patient's discharge due to the unfavorable prognosis. The patient died after approximately 3 months. contact with small bowel loops, ascending colon, right psoas muscle, imprinting the right ureter, the inferior vena, and the right common iliac artery, abdominal enlarged lymph nodes, minimum ascites, and 1st degree right uretero-hydronephrosis due to compression. The patient benefited by partial surgical resection of the tumor, and the histopathological exam established the diagnosis of non-Hodgkin lymphoma, mostlikely BL.
2.2.4. Therapeutic focus and assessment. We initiated the B-NHL BFM 04 cytostatic protocol, but on the 1st day after the first cure of chemotherapy (AA-24), the patient developed a severe medullary aplasia for which he received substitutive treatment (erythrocyte and PLT mass, human albumin), growth factor for granulocyte colonies, wide spectrum antibiotics, and supportive treatment. Epstein Barr virus were within normal ranges. The medullar biopsy was negative. The abdominal ultrasound was hindered by the patient's severe bloating, but it revealed ascites. Therefore, we decided to repeat the abdominal CT scan that revealed severe stasis at the gastro-duodenal level, a fistula between the proximal jejunal loops and the descending colon, ischemia of the bowel loops, mesenteric enlarged lymph nodes, and minimal adjacent fluid collections. Based on all these findings, the patient underwent an exploratory laparotomy that revealed a tumor mass involving the left colic angle, the terminal part of the duodenum, and the angle between the duodenum and the jejunum, with covered perforations at the level of the duodenum, jejunum, and colon. A partial surgical resection was performed, and the histopathological exam established the diagnosis of BL.
2.4.4. Therapeutic focus and assessment. The patient's evolution after the surgical intervention was initially burdened by multiple complications, and therefore, he underwent multiple re-interventions. After approximately 2 weeks, we were not only initiated the cytostatic B-NHL BFM 04 protocol, but also supportive treatment with favorable evolution.
2.4.5. Follow-up and outcome. The patient completed the chemotherapy without any major incidents. His evolution was favorable within the next 2 years after the diagnosis, but unfortunately, he eventually developed a relapse consisting in a retroperitoneal tumor mass and cerebral metastasis. Therefore, his parents refused treatment and he died.
Discussions
The incidence of lymphomas varies worldwide, 60% being classified as NHL, accounting for 8% of all pediatric malignant conditions. [4] [5] [6] In approximately 70% of patients diagnosed with NHL, the onset of the disease involves extranodal involvement, such as bone marrow and central nervous system impairment, being labeled as stage III or IV tumors. [1] Only one of our patients presented with advanced disease, diagnosed with stage IV BL due to the central nervous system metastasis. Despite this fact, he was the only one who survived. Sporadic BL is the most common [7] The most common onset age reported in the literature for BL is between 5 and 9 years of age. [8] [9] [10] Most frequently, BL affects males, [8, 9] but it can also appear in females. [10] Similarly, our 3 cases diagnosed with BL were males, 2 with the age between 5 and 9 years, and 1 close to the age of 5 years, that is, 4 years and 10 months. The onset age for BL differs depending on the subtypes, therefore usually endemic BL appears at younger ages, 5 to 6 years of age in comparison to sporadic BL, 8 to 9 years of age. [11, 12] Also, according to the study performed by Stefan and Lutchman, [13] white population tends to follow the sporadic pattern of BL. Even though our patients belong to the Caucasian population and therefore presented with sporadic BL, only 1 of 3 diagnosed with this type of malignancy had the age of 8 years, the other 2 tended to follow the endemic pattern of BL due to the younger age of onset, approximately 5 years.
It is well-known that the gastrointestinal tract is one of the most common sites for NHL, and that up to 90% of the primary gastrointestinal lymphomas are of B-cell origin. [14, 15] B-cell NHL comprises BL and DLCBL. These types of malignancies affecting the gastrointestinal tract can manifest with different symptoms, such as abdominal pain, anorexia, weight loss, diarrhea, and ileus. [16] All of our 4 cases presented abdominal pain, 2 also presented diarrhea, anorexia was encountered in 2 of the 4 cases described above, while weight loss was found in only 1 case. In rare cases, DLBCL can also lead to bowel intussusception. [14, 17] In addition to intussusception, presenting symptoms of both BL and DLBCL can also mimic appendicitis. Similarly, one of our patients with BL was initially admitted in the Pediatrics Surgery Clinic with the diagnosis of appendicitis. It is well-documented that sporadic or nonendemic BL has, in most of the cases (91%), an abdominal presentation affecting the distal ileum, the stomach, the cecum and/or mesentery, the kidneys, testis/ovary (6%), but it can also involve the breast, bone marrow (20%), and/or central nervous system (14%). [18] Similarly, all 4 cases described above were diagnosed with abdominal NHL. Among them, 2 out of 4 involved the colon, 1 affected the cecum, and 1 also extended to the small bowel. The literature also reported that BL can rarely involve the pancreas. [19, 20] In addition, bone marrow involvement is encountered in under 10% of the cases at onset, but is more frequent in case of recurrence or with treatment resistance. [21] Of our 3 cases diagnosed with BL none presented bone marrow involvement, either the one with IV-stage BL, but in exchange that patient presented central nervous system metastasis. The diagnosis of NHL is suspected based on ultrasound or CT scans, but it is only confirmed by the histopathological exam. Nevertheless, a careful ultrasound exam performed by an experimented individual will guide the diagnosis very well. [22] CT scan is a useful diagnostic tool in case of patients with abdominal masses that can guide properly the surgical intervention, but it also establishes the exact stage of the tumor or the mediastinal adenopathies, and pleural, pericardial, renal, muscle, and peritoneal metastases. [23] Even though CT scans are very important for the diagnosis of abdominal tumors, in one of our cases this exam was not relevant, and therefore, we were forced to perform an exploratory laparotomy in order to identify the exact cause of the patient's symptoms.
The prognosis of children diagnosed with NHL is reported as very good, even in those with advanced disease. Due to the advances in the management of these cases, the prognosis children diagnosed with this type of tumor improved very much in the last decades. According to the studies performed on children below the age of 15 years, the survival rate at the ages of 5 and 10 years increased from 76.6% and 73%, respectively, between 1990 and 1994 to 87.7% and 86.9%, respectively, between 2000 and 2004. Even better, the survival rate at the age of 10 years in case of children diagnosed between 2005 and 2009 improved to 90.6%. [24] Despite all these data, only one of our patients diagnosed with NHL survived 2 years after the diagnosis. Many studies tried to identify the factors that influence the prognosis, and some of them underlined that high levels of LDH may be a negative prognostic factor for these patients. [25] Contrariwise, in our series of cases, only one patient of all 3 who died, presented a severely increased level of LDH.
Conclusions
NHL is one of the most aggressive tumors of childhood. Its clinical manifestations depend mostly on the tumor site. The prognosis of these tumors is not mandatory influenced by the tumor stage because the survival rate can be high even in cases of advanced stages at onset. Despite all these facts, NHL remains a fatal condition in children.
